Year-over-year articles
ACTIVE PHARMA AS
7 crawlable comparisons of consecutive annual reports.
Full company analysis · Org.nr 922 581 150
Grew 108111% on revenue, stronger earnings
Comparing Årsregnskap 2025 with 2024 for ACTIVE PHARMA AS. Revenue 506 NOK → 547.5k NOK (+108111.1%). Net result +12.7k NOK → +87.1k NOK. Equity 47.1k NOK →…
Shrank 100% on revenue, weaker earnings
Comparing Årsregnskap 2024 with 2023 for ACTIVE PHARMA AS. Revenue 412.3k NOK → 506 NOK (-99.9%). Net result +212.0k NOK → +12.7k NOK. Equity 34.4k NOK →…
Shrank 39% on revenue, stronger earnings, cash halved-plus
Comparing Årsregnskap 2023 with 2022 for ACTIVE PHARMA AS. Revenue 670.8k NOK → 412.3k NOK (-38.5%). Net result +66.0k NOK → +212.0k NOK. Equity -177.6k NOK…
Shrank 55% on revenue, weaker earnings
Comparing Årsregnskap 2022 with 2021 for ACTIVE PHARMA AS. Revenue 1.51m NOK → 670.8k NOK (-55.5%). Net result +464.0k NOK → +66.0k NOK. Equity -377.0k NOK…
Grew 368% on revenue, returned to profit, cash halved-plus
Comparing Årsregnskap 2021 with 2020 for ACTIVE PHARMA AS. Revenue 321.7k NOK → 1.51m NOK (+368.2%). Net result -267.0k NOK → +464.0k NOK. Equity -841.0k…
Shrank 51% on revenue, stronger earnings
Comparing Årsregnskap 2020 with 2019 for ACTIVE PHARMA AS. Revenue 660.8k NOK → 321.7k NOK (-51.3%). Net result -668.4k NOK → -267.0k NOK. Equity -574.0k…
First published accounts
First year in the published series for ACTIVE PHARMA AS (2019). No prior-year comparative in this dataset.